BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 15, 2024
See today's BioWorld
Home
» Other news to note for Dec. 1, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Dec. 1, 2020
Dec. 1, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abfero, Actavis, Adamis, Amarin, Anixa, Astrazeneca, Auris, Beigene, Bioclonetics, Biohaven, Casma, Cel-Sci, Chrysalis, Dragonfly, Elevar, Entheon, Enzolytics, ERS, Eversana, Grünenthal, Helsinn, Hikma, Horizon, Janssen, Kyowa Kirin, Luca, Macrogenics, Merck & Co., Newstem, Novelstem, Outlook Sanyou, Sesen, Sosei, Specifica, Sun, Tris, UCB, Vigeneron, Vipergen, Vivlion, Wuxi Apptec, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus